VICTORIA FORD: Open Payments
NPI 1225281868 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,582 in 172 payments from 20 companies in 2025. Trend: 2023 $2,253 · 2024 $2,449 · 2025 $2,582
Food & beverage: $2,483Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $457 |
| Novartis Pharmaceuticals Corporation | 27 | $354 |
| Regeneron Healthcare Solutions, Inc. | 7 | $239 |
| LEO Pharma Inc. | 13 | $205 |
| Incyte Corporation | 11 | $195 |
| GENZYME CORPORATION | 7 | $172 |
| Galderma Laboratories, L.P. | 12 | $163 |
| Amgen Inc. | 7 | $116 |
| Arcutis Biotherapeutics, Inc. | 6 | $110 |
| Janssen Biotech, Inc. | 4 | $108 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, OPZELURA, RINVOQ, ADBRY, Otezla, Zoryve.
Industry payments across MS — which companies pay providers there.
